UK Gov Recalls Sodium Chloride Solutions Made Apr-Nov 2023

Batches of irrigation, inhalation and eyewash solutions manufactured by Legency Remedies Pvt Ltd are being recalled as a precaution, due to potential contamination with the bacteria Ralstonia pickettii.

Whilst Ralstonia pickettii rarely causes an infection and the health risk to most people is very low, individuals with a weakened immune system are more likely to be affected. Those using the affected products should stop doing so and return them to their supplier or retailer.

These products have a wide range of uses within healthcare settings such as hospitals, but can also be used outside of healthcare organisations, for example as part of first aid kits purchased from shops.

The brand names of the affected products are:

  • Sodium Chloride Irrigation Solution 0.9 % w/v 20 ml (Blue Dot)
  • Sodium Chloride Inhalation Solution 0.9 % w/v 2.5 ml
  • Aerowash 20 ml Eyewash

Individuals and organisations can check if they have any of the affected batches listed in the company's Field Safety Notice (FSN) by looking for the batch numbers on the product packaging. Any affected products should be returned promptly to their original place of purchase. This will only affect products manufactured by Legency Remedies Pvt Ltd between April and November 2023.

If you have been using a recalled product and have been feeling unwell, for example experiencing shaking or shivering and a raised temperature, you should inform a healthcare professional.

Retailers have been advised, where possible, to contact patients who have purchased any of the affected batches and ask them to return the product.

The MHRA has published a Devices Safety Information notice to notify those within healthcare settings, including hospitals and care homes, of the recall.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.